{
  "ticker": "JNJ",
  "target_date": "2025-08-18",
  "actual_date": "2025-08-18",
  "collected_at": "2025-12-08T12:09:16.108988",
  "price": {
    "open": 174.11,
    "high": 175.16,
    "low": 173.71,
    "close": 173.86184692382812,
    "volume": 9284000,
    "change_1d_pct": -0.22,
    "change_7d_pct": 2.75,
    "change_30d_pct": 13.51
  },
  "technicals": {
    "rsi_14": 71.83,
    "sma_20": 168.41,
    "sma_50": 159.58,
    "macd": 3.981,
    "macd_signal": 3.771,
    "macd_histogram": 0.21,
    "bb_upper": 175.13,
    "bb_lower": 161.68,
    "price_vs_sma20_pct": 3.24,
    "price_vs_sma50_pct": 8.95,
    "volume_ratio": 1.1
  },
  "fundamentals": {
    "market_cap": 488364113920,
    "pe_ratio": 19.565638,
    "forward_pe": 19.12264,
    "price_to_book": 6.1523056,
    "price_to_sales": 5.2997227,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.46,
    "pct_from_52w_low": 44.09
  },
  "macro": {
    "spy": {
      "price": 641.52,
      "change_1d_pct": -0.02,
      "change_7d_pct": 0.96
    },
    "vix": {
      "level": 14.99,
      "signal": "LOW_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.34
    },
    "dollar_index": {
      "level": 98.17
    },
    "gold": {
      "price": 3331.7
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Columbia Dividend Income Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1755545400,
      "summary": "Columbia Threadneedle Investments reports Q2 underperformance for its Dividend Income Fund amid tech and healthcare headwinds. See how quality stocks remain central.\n",
      "url": "https://finnhub.io/api/news?id=abdcfc7414c024b4a1ef96ab2faac9bbdfb29f442859ed22402764565c78c6b5"
    },
    {
      "headline": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
      "source": "Yahoo",
      "datetime": 1755522005,
      "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=91652647278ac58ac8719c423e4000d9bb315f5cbfd7ae628835c1c7ba089b06"
    },
    {
      "headline": "Here's How You Can Earn $100 In Passive Income By Investing In Johnson & Johnson Stock",
      "source": "Yahoo",
      "datetime": 1755518462,
      "summary": "Johnson & Johnson (NYSE:JNJ) is a global healthcare company that researches, develops, and manufactures a wide range of pharmaceutical products, medical devices, and consumer health products. It will report its Q3 2025 earnings on Oct. 14. Wall Street ...",
      "url": "https://finnhub.io/api/news?id=986969e8a6654ff4bdc33b4d7c20215bc41de5b3f33bf9f09ede0d0b0ba73892"
    },
    {
      "headline": "Macquarie Value Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1755474300,
      "summary": "For the second quarter, Macquarie Value Fund Institutional Class shares trailed its benchmark, the Russell 1000\u00c2\u00ae Value Index. Read more here.",
      "url": "https://finnhub.io/api/news?id=7f029f701046186913fcd04ac3c08f98450200c79587e25d76e190c6fd16d965"
    },
    {
      "headline": "Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm",
      "source": "Yahoo",
      "datetime": 1755472980,
      "summary": "These companies have successfully navigated similar obstacles before.",
      "url": "https://finnhub.io/api/news?id=e1bc57aec5f89c58b5490ff038dd5e6e459418ff20cdb58087b7b63f7356bdc2"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-18",
      "description": "xslF345X05/wk-form4_1755555550.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}